References
- 1. Longo DL, Kasper DL, Jameson JL, et al. Harrison’s Principles of Internal Medicine, 18th edition, The McGraw-Hill Companies/United States of America; 2012. p. 723-730.
- 2. Tejera-Vaquerizo A, Martín-Cuevas P, Gallego E, et al. Predictors of Sentinel Lymph Node Status in Cutaneous Melanoma: A Classification and Regression Tree Analysis. Actas Dermosifiliogr. 2015;106:208-218.
- 3. Garbe C, Peris K, Hauschild A, et al. Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guideline. Eur J Cancer. 2010;4:270-283.
- 4. Ellis MC, Weerasinghe R, Corless CL, et al. Sentinel lymph node staging of cutaneous melanoma: predictors and outcomes. Am J Surg. 2010;199:663-668.
- 5. Teixeira V, Vieira R, Coutinho I, et al. Prediction of Sentinel Node Status and Clinical Outcome in a Melanoma Centre. Journal of Skin Cancer. 2013;2013:7.
- 6. Kibrité A, Milot H, Douville P, et al. Predictive factors for sentinel lymph nodes and non-sentinel lymph nodes metastatic involvement: a database study of 1,041 melanoma patients. Am J Surg. 2016;211:89-94.
- 7. Morton ML, Thompson JF, Cochran AC, et al. Final Trial Report of Sentinel-Node Biopsy versus Nodal Observation in Melanoma. N Engl J Med. 2014;370:599-609.
- 8. Gershenwald JE, Ross MI. Sentinel-Lymph-Node Biopsy for Cutaneous Melanoma. N Engl J Med. 2011;364:1738-1745.
- 9. Choi EA, Gershenwald JE. Imaging studies in patients with melanoma. Surg Oncol Clin N Am. 2007;16:403-430.10.1016/j.soc.2007.03.004
- 10. Faries MB, Cochran AJ, Elashoff RM, et al. Multicenter Selective Lymphadenectomy Trial-I confirms the central role of sentinel node biopsy in contemporary melanoma management. Br J Dermatol. 2015;172:571-573.